We’re committed to advancing medicine by finding new and improved ways to diagnose and treat cancer that deliver better life outcomes for patients across the world
A Study to Determine Dose, Safety, Tolerability and Efficacy of CC-220 Monotherapy, and in Combination With Other Treatments in Subjects With Multiple Myeloma
Ongoing 2022
Cancer
LIT study
Breast cancer
Evaluation of LIT test as a marker for immunocompetence in chemotherapy
Ongoing 2022
Cancer
DCISionRT® Registry
Breast cancer
A Prospective Registry Study to Evaluate the Effect of the DCISionRT Test on Treatment Decisions in Patients with DCIS Following Breast Conserving Therapy